Quick search:
news >>
News
HC21 introduce Mallinckrodt/Covidien's OptiMARK & Optistar LE
Healthcare 21 are pleased to launch Mallinckrodt/Covidien’s MR contrast media OptiMARK and injector system Optistar LE to Ireland.
OptiMARK
OptiMARK is the only MR contrast agent FDA-approved for administration by power injector. OptiMARK® is a gadolinium based, IV contrast media. OptiMARK® has convenient packaging options for just the right amount of contrast. You can trust OptiMARK® to have a good safety profile and to give you the diagnostic accuracy you expect from a gadolinium extracellular agent.
Features and benefits:
- A Non-Ionic, Lower Osmolar, Lower Viscosity Agent
- Good Image Quality
- A good safety profile
- The first and only MRI agent approved for power injection
- Single-dose vials in a range of sizes and a convenient multi-dose bottle
- A selection of pre-filled plastic syringes to aid in safer and easier injections and help to increase efficiency
Indications and Applications:
CNS (Central Nervous System) and LIVER
Optistar® LE Power Injector
Contrast media power injector for use with contrast enhanced MRI procedures.
Total Integrated MR System:
- OptiMARK® pre-filled syringes plus OptiSTAR® LE
Features and Benefits:
- Battery Free
- Color Touch Screen Techology
- Programmable User Defined Stored Settings
- Utilizes OptiMARK® Pre-Filled Syringes
- Dual Injection Channels for Contrast and Saline Flush
Go to http://imaging.mallinckrodt.com for more information